Randomized Double-blind, Active-controlled Phase 3 Study to Assess 12-Month Safety and Efficacy of Mirabegron, a β3-Adrenoceptor Agonist, in Overactive Bladder
Keywords: مثانه بیش فعال; Mirabegron; Tolterodine; Overactive bladder